On Sep 29, 2021 BioAtla closed a Post-IPO Equity round and raised $75,000,000 from Cormorant Asset Management, Deerfield Management, Great Point Partners, HBM Healthcare Investments AG, Hudson Bay Capital Management, Ikarian Capital, Monashee Investment Management, Pappas Capital, Soleus Capital, Sphera Global Healthcare Fund, featuring lead investors .

About the company: BioAtla is located at United States, North America.
“Revolutionizing cancer therapy with Conditionally Active Biologics™”

Company website: http://www.bioatla.com